Journal Of Clinical Oncology (jco) Podcast
HER3-DXd in EGFR-Mutated NSCLC: HERTHENA-Lung01
- Autor: Vários
- Narrador: Vários
- Editor: Podcast
- Duración: 0:16:22
- Mas informaciones
Informações:
Sinopsis
Dr. Shannon Westin and her guest, Dr. Helena Yu discuss the paper "HERTHENA-Lung01, a Phase 2 Trial of Patritumab Deruxtecan (HER3-DXd) in EGFR-Mutated NSCLC Following EGFR TKI Therapy and Platinum-Based Chemotherapy" published in the JCO during the World Conference on Lung Cancer in Singapore.
